Key facts
- This page summarizes Jyoti Palaniappan's Form 4 filing for Adaptive Biotechnologies Corp (ADPT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Jul 2021, 21:00.
Jyoti Palaniappan - 19 Jul 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)
- Reporting relationship
- SVP, Diagnostics, T-Detect
- Issuer ticker
- ADPT
- Reported as of
- 19 Jul 2021
- Net transaction value
- -$8,834
- SEC form
- 4
- Accepted by SEC
- 19 Jul 2021, 21:00:28 UTC
- Prior SEC filing
- 21 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jyoti Palaniappan by Eric Billings as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jyoti Palaniappan filed Form 4 for Adaptive Biotechnologies Corp (ADPT) on 19 Jul 2021.
Change
- Previous filing in this sequence was filed on 21 Jun 2021.
- Current net transaction value: -$8,834.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADPT
transaction
Common Stock
Options Exercise
- Transaction value
- $14,680
- Shares
- +651
- Change %
- +7.1%
- Price
- $22.55
- Shares after
- 9,809
- Date
- 19 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
ADPT
transaction
Common Stock
Sale
- Transaction value
- $23,514
- Shares
- -651
- Change %
- -6.6%
- Price
- $36.12*
- Shares after
- 9,158
- Date
- 19 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADPT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -651
- Change %
- -0.62%
- Price
- $0.000000
- Shares after
- 104,393
- Date
- 19 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 651
- Exercise price
- $22.55
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
Footnote F2
The options vested with respect to 1/4 of such shares on March 18, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.